Membrane‐Active Peptide Protects Against Inflammation by Targeting NLRP3 Activation at the Trans‐Golgi Network
Advanced Science · 2026
DOI: 10.1002/advs.76587 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2026. Verfasst von Jonas Engelhardt und 16 weiteren Autor:innen. Beteiligte Einrichtung: Pharmaceutical Institute, Section Pharmacology and Toxicology, University of Bonn, Bonn, Germany. Hauptthemen laut MEDLINE: NLR Family, Pyrin Domain-Containing 3 Protein, trans-Golgi Network, Inflammation, Inflammasomes. Die Arbeit nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft (DFG, German Research Foundation), European Research Council (ERC Advanced Grant), Leibniz Research Alliance 'Leibniz Health Technologies'.
Abstract (Originalsprache)
The NLRP3 inflammasome is a multi‐protein complex that plays a crucial role in inflammatory processes mediated by the innate immune system. Dysregulated NLRP3 activation has been implicated in age‐related inflammatory diseases, making it a promising therapeutic target. Here, we report that the synthetic membrane‐active antimicrobial peptide Pep19‐2.5 directly inhibits NLRP3 inflammasome activation. Through cellular, biophysical, and biochemical analyses, we find that Pep19‐2.5 suppresses NLRP3 inflammasome signaling downstream of NLRP3 activation. Pep19‐2.5 interacts with macrophage membranes, supporting a membrane‐targeting mechanism for its anti‐inflammatory effects. Mechanistically, Pep19‐2.5 binds to phosphatidylinositol (PI)‐containing lipid membranes and dispersed trans‐Golgi network (dTGN) structures, which could potentially affect NLRP3 recruitment to the dTGN. We demonstrate a strong and NLRP3‐dependent induction of IL‐1β secretion from human macrophages by house dust mite (HDM) extract, which can be inhibited by Pep19‐2.5. In line with these findings, therapeutic application of Pep19‐2.5 via the nasal aerosol route reduces IL‐1β levels, eosinophil infiltration in bronchoalveolar lavage and significantly improved lung function in an in vivo HDM‐mouse model of allergic airway inflammation. Our findings highlight the therapeutic potential of targeting NLRP3 activation by the small membrane‐active peptide Pep19‐2.5 for the treatment of NLRP3‐driven inflammatory diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Pharmaceutical Institute, Section Pharmacology and Toxicology, University of Bonn, Bonn, Germany.
- Division of Immunobiophysics, Priority Area Infections, Research Center Borstel, Leibniz Lung Center, Member of Leibniz Health Technologies, Borstel, Germany.
- Division of Lung Immunology, Priority Area Chronic Lung Diseases, Research Center Borstel, Leibniz Lung Center, Borstel, Germany.
- Airway Research North (ARCN), German Center for Lung Research (DZL), Borstel, Germany.
- Institute of Structural Biology, University of Bonn, Bonn, Germany.
- Wellcome-Wolfson Institute for Experimental Medicine, Queen's University Belfast, Belfast, UK.
ORCID-Profile: Nico Kirsch, Lars P Lunding, Dominic Ferber, Hannes Buthmann, Rebecca C Coll, Lena Bauernhofer, Sandro Keller, Matthias Geyer, Michael Wegmann, Andra B Schromm, Günther Weindl
Förderung
- Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)
- European Research Council (ERC Advanced Grant)
- Leibniz Research Alliance 'Leibniz Health Technologies'
- Studienstiftung des deutschen Volkes, Bonn, Germany
Zitieren
APA
Engelhardt, J., Kirsch, N., Kerfin, A., Lunding, L. P., Ferber, D., Buthmann, H., Schreier, I., Bosio, C., Dobbelstein, A. K., Klawonn, A., Coll, R. C., Bauernhofer, L., Keller, S., Geyer, M., Wegmann, M., Schromm, A. B., & Weindl, G. (2026). Membrane‐Active Peptide Protects Against Inflammation by Targeting NLRP3 Activation at the Trans‐Golgi Network. Advanced Science. https://doi.org/10.1002/advs.76587
Vancouver
Engelhardt J, Kirsch N, Kerfin A, Lunding LP, Ferber D, Buthmann H, et al. Membrane‐Active Peptide Protects Against Inflammation by Targeting NLRP3 Activation at the Trans‐Golgi Network. Advanced Science. 2026. doi:10.1002/advs.76587
BibTeX
@article{Engelhardt2026,
author = {Engelhardt, Jonas and Kirsch, Nico and Kerfin, Aileen and Lunding, Lars P and Ferber, Dominic and Buthmann, Hannes and Schreier, Ilka and Bosio, Carlotta and Dobbelstein, Ann-Kathrin and Klawonn, Anna and Coll, Rebecca C and Bauernhofer, Lena and Keller, Sandro and Geyer, Matthias and Wegmann, Michael and Schromm, Andra B and Weindl, Günther},
title = {Membrane‐Active Peptide Protects Against Inflammation by Targeting NLRP3 Activation at the Trans‐Golgi Network},
journal = {Advanced Science},
year = {2026},
doi = {10.1002/advs.76587}
}
EUVIMED